New York Hospital-Cornell Medical Center

New York, New York 10021

0 studies enrolling now · 5 studies all time

What they study most

Bloom Syndrome, Lymphoma, Low-Grade, Mantle Cell Lymphoma, Multiple Sclerosis, Relapsing-Remitting, Purpura, Thrombocytopenic, Idiopathic

Studies at this site

• Multiple Rising Does Study (Subcutaneous Doses) of BI 655064 in Male and Female Patients With Chronic Primary Immune Thrombocytopenic Purpura (ITP). — Stopped early
• Safety and Efficacy of Natalizumab in Combination With Avonex in the Treatment of Multiple Sclerosis — Completed
• VELCADE in Subjects With Relapsed or Refractory Mantle Cell Lymphoma — Completed
• Biological Significance of the Bloom's Syndrome Protein — Completed
• Idiotype Vaccine for Low-Grade Non-Hodgkin's Lymphoma — Status unconfirmed